268 related articles for article (PubMed ID: 10218421)
1. [Diagnostic and therapeutic value of synthetic or recombinant allergens].
Spertini F
Rev Med Suisse Romande; 1999 Mar; 119(3):235-9. PubMed ID: 10218421
[TBL] [Abstract][Full Text] [Related]
2. [Natural allergens and recombinant allergens].
Deviller P
Allerg Immunol (Paris); 1995 Nov; 27(9):316-9. PubMed ID: 8590581
[TBL] [Abstract][Full Text] [Related]
3. From allergen genes to new forms of allergy diagnosis and treatment.
Vrtala S
Allergy; 2008 Mar; 63(3):299-309. PubMed ID: 18269675
[TBL] [Abstract][Full Text] [Related]
4. Recombinant allergens for diagnosis and therapy of allergic disease.
Chapman MD; Smith AM; Vailes LD; Arruda LK; Dhanaraj V; Pomés A
J Allergy Clin Immunol; 2000 Sep; 106(3):409-18. PubMed ID: 10984358
[TBL] [Abstract][Full Text] [Related]
5. Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens.
Pittner G; Vrtala S; Thomas WR; Weghofer M; Kundi M; Horak F; Kraft D; Valenta R
Clin Exp Allergy; 2004 Apr; 34(4):597-603. PubMed ID: 15080813
[TBL] [Abstract][Full Text] [Related]
6. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
Crameri R
Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
[TBL] [Abstract][Full Text] [Related]
7. [Interests of recombinant allergens in the practice of allergy].
Karoui O; Leimgruber A; Spertini F
Rev Med Suisse; 2013 Jan; 9(368):22-7. PubMed ID: 23367699
[TBL] [Abstract][Full Text] [Related]
8. Recombinant allergens for immunotherapy.
Valenta R; Niederberger V
J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
[TBL] [Abstract][Full Text] [Related]
9. [Recombinant allergens for diagnosis and specific immunotherapy--value in pediatric patients].
Couderc R; Just J
Bull Acad Natl Med; 2013 Mar; 197(3):645-59; discussion 659-60. PubMed ID: 25163347
[TBL] [Abstract][Full Text] [Related]
10. Allergen-related approaches to immunotherapy.
Rolland JM; Gardner LM; O'Hehir RE
Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
[TBL] [Abstract][Full Text] [Related]
11. [Recombinant allergens: diagnostic use and therapeutic perspectives].
Pauli G; Deviller P
Rev Mal Respir; 2000 Feb; 17(1 Pt 2):293-303. PubMed ID: 10902143
[TBL] [Abstract][Full Text] [Related]
12. Advances in mosquito allergy.
Peng Z; Simons FE
Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):350-4. PubMed ID: 17620829
[TBL] [Abstract][Full Text] [Related]
13. Laboratory tests for diagnosis of food allergy: advantages, disadvantages and future perspectives.
Moneret-Vautrin DA; Kanny G; Frémont S
Eur Ann Allergy Clin Immunol; 2003 Apr; 35(4):113-9. PubMed ID: 12793113
[TBL] [Abstract][Full Text] [Related]
14. Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy.
Valenta R; Vrtala S; Focke-Tejkl M; Bugajska-Schretter ; Ball T; Twardosz A; Spitzauer S; Grönlund H; Kraft D
Biol Chem; 1999; 380(7-8):815-24. PubMed ID: 10494830
[TBL] [Abstract][Full Text] [Related]
15. Genetically modified allergens.
Niederberger V; Valenta R
Immunol Allergy Clin North Am; 2004 Nov; 24(4):727-38. PubMed ID: 15474868
[TBL] [Abstract][Full Text] [Related]
16. Latex allergy: a model for therapy.
Rolland JM; O'Hehir RE
Clin Exp Allergy; 2008 Jun; 38(6):898-912. PubMed ID: 18498539
[TBL] [Abstract][Full Text] [Related]
17. Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen-specific immunotherapy.
González-Rioja R; Ibarrola I; Arilla MC; Ferrer A; Mir A; Andreu C; Martínez A; Asturias JA
J Allergy Clin Immunol; 2007 Sep; 120(3):602-9. PubMed ID: 17561242
[TBL] [Abstract][Full Text] [Related]
18. A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6.
Linhart B; Mothes-Luksch N; Vrtala S; Kneidinger M; Valent P; Valenta R
Biol Chem; 2008 Jul; 389(7):925-33. PubMed ID: 18627317
[TBL] [Abstract][Full Text] [Related]
19. Sublingual reactivity to rBET V1 and rPHL P1 in patients with oral allergy syndrome.
Marcucci F; Sensi L; Di Cara G; Gidaro G; Incorvaia C; Frati F
Int J Immunopathol Pharmacol; 2006; 19(1):141-8. PubMed ID: 16569352
[TBL] [Abstract][Full Text] [Related]
20. Strategies for converting allergens into hypoallergenic vaccine candidates.
Vrtala S; Focke-Tejkl M; Swoboda I; Kraft D; Valenta R
Methods; 2004 Mar; 32(3):313-20. PubMed ID: 14962766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
